Literature DB >> 15808708

Unfolding knowledge on cerebral cavernous malformations.

Issam A Awad1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808708     DOI: 10.1016/j.surneu.2004.12.032

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


× No keyword cloud information.
  5 in total

1.  Role of Krev Interaction Trapped-1 in Prostacyclin-Induced Protection against Lung Vascular Permeability Induced by Excessive Mechanical Forces and Thrombin Receptor Activating Peptide 6.

Authors:  Angelo Meliton; Fanyong Meng; Yufeng Tian; Alok A Shah; Anna A Birukova; Konstantin G Birukov
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

2.  Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.

Authors:  Romuald Girard; Maged D Fam; Hussein A Zeineddine; Huan Tan; Abdul Ghani Mikati; Changbin Shi; Michael Jesselson; Robert Shenkar; Meijing Wu; Ying Cao; Nicholas Hobson; Henrik B W Larsson; Gregory A Christoforidis; Issam A Awad
Journal:  J Neurosurg       Date:  2016-08-05       Impact factor: 5.115

3.  Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.

Authors:  Asya L Borikova; Christopher F Dibble; Noah Sciaky; Christopher M Welch; Amy N Abell; Sompop Bencharit; Gary L Johnson
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

Review 4.  Clinical Management of Cavernous Malformations.

Authors:  Kelly D Flemming
Journal:  Curr Cardiol Rep       Date:  2017-10-18       Impact factor: 2.931

5.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.